INTERNATIONAL PATENT: MITSUBISHI TANABE PHARMA CORPORATION, 田辺三菱製薬株式会社 FILES APPLICATION FOR "NEW CRYSTAL OF (2R)-N-BENZYL-1-[5-(2-FLUOROPROPANE-2-YL)-7-OXO-6,7-DIHYDRO[1,3]THIAZOLO[5,4-D]PYRIMIDIN-2-YL]PYRROLIDINE-2-CARBOXAMIDE AND METHOD FOR PRODUCING SAME"

GENEVA, Feb. 3 -- MITSUBISHI TANABE PHARMA CORPORATION (3-2-10, Dosho-machi, Chuo-ku, Osaka-shi, Osaka5418505), 田辺三菱製薬株式会社 (大阪府大阪市中央区道修町三丁目２番１０号) filed a patent application (PCT/JP2025/026329) for "NEW CRYSTAL OF (2R)-N-BENZYL-1-[5-(2-FLUOROPROPANE-2-YL)-7-OXO-6,7-DIHYDRO[1,3]THIAZOLO[5,4-D]PYRIMIDIN-2-YL]PYRROLIDINE-2-CARBOXAMIDE, AND METHOD FOR PRODUCING SAME" on Jul 24, 2025. With publication no. WO/2026/023672, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitt...